
Fluidigm Corporation Retained Earnings 2011-2026 | FLDM
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Fluidigm Corporation
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| - | -624 M | -559 M | -500 M | -439 M | -363 M | -310 M | -257 M | -241 M | -222 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -222 M | -624 M | -391 M |
Retained Earnings of other stocks in the Diagnostics research industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Co-Diagnostics
CODX
|
-80.4 M | $ 1.29 | -20.63 % | $ 1.72 M | ||
|
Centogene N.V.
CNTG
|
-62.9 M | - | -6.23 % | $ 30.6 M | ||
|
Fulgent Genetics
FLGT
|
590 M | $ 15.93 | -1.61 % | $ 482 M | ||
|
Agilent Technologies
A
|
348 M | $ 112.11 | -1.0 % | $ 34.1 B | ||
|
Castle Biosciences
CSTL
|
-224 M | $ 19.08 | 1.06 % | $ 553 M | ||
|
Akumin
AKU
|
-280 M | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
-544 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-607 M | - | -61.36 % | $ 2.46 M | ||
|
Illumina
ILMN
|
-1.24 B | $ 140.65 | -1.81 % | $ 22.4 B | ||
|
Biocept
BIOC
|
-298 M | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-84 M | - | - | $ 562 M | ||
|
Interpace Biosciences
IDXG
|
-211 M | $ 1.8 | - | $ 7.96 M | ||
|
CareDx, Inc
CDNA
|
-735 M | $ 19.81 | -3.32 % | $ 1.06 B | ||
|
Chembio Diagnostics
CEMI
|
-154 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-166 M | - | - | $ 9.42 M | ||
|
Lantheus Holdings
LNTH
|
680 M | $ 93.98 | -2.78 % | $ 6.34 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-230 M | - | -20.0 % | $ 1.06 M | ||
|
Medpace Holdings
MEDP
|
-460 M | $ 419.51 | 0.08 % | $ 12.1 B | ||
|
Mettler-Toledo International
MTD
|
9.24 B | $ 1 046.9 | 0.48 % | $ 21.6 B | ||
|
Global Cord Blood Corporation
CO
|
2.89 B | - | - | $ 399 M | ||
|
Myriad Genetics
MYGN
|
-1.12 B | $ 3.61 | -0.28 % | $ 334 M | ||
|
Genetic Technologies Limited
GENE
|
-150 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-4.94 B | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-424 M | - | -11.32 % | $ 2.94 M | ||
|
NeoGenomics
NEO
|
-434 M | $ 8.28 | -1.02 % | $ 1.06 B | ||
|
Charles River Laboratories International
CRL
|
1.39 B | $ 155.13 | -2.51 % | $ 7.69 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
440 M | - | - | $ 10.7 B | ||
|
National Research Corporation
NRC
|
-17.3 M | $ 18.58 | -1.85 % | $ 416 M | ||
|
Natera
NTRA
|
-1.94 B | $ 187.34 | -4.86 % | $ 18.4 B | ||
|
Enzo Biochem
ENZ
|
-294 M | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
-4.71 B | - | - | $ 19.8 B | ||
|
Guardant Health
GH
|
-2.99 B | $ 93.18 | -5.56 % | $ 11.7 B | ||
|
Senseonics Holdings
SENS
|
-1.02 B | $ 5.73 | -1.63 % | $ 239 M | ||
|
Personalis
PSNL
|
-631 M | $ 6.5 | -3.2 % | $ 580 M | ||
|
Heska Corporation
HSKA
|
-169 M | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
2.72 B | $ 117.79 | 0.6 % | $ 9.72 B | ||
|
Soleno Therapeutics
SLNO
|
-431 M | $ 52.99 | - | $ 2.69 B | ||
|
QIAGEN N.V.
QGEN
|
2.75 B | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
-53.2 M | $ 2.36 | -2.07 % | $ 5.42 M | ||
|
Laboratory Corporation of America Holdings
LH
|
8.64 B | $ 252.4 | -0.64 % | $ 21 B | ||
|
Thermo Fisher Scientific
TMO
|
59.2 B | $ 441.45 | -1.49 % | $ 166 B | ||
|
Trinity Biotech plc
TRIB
|
-79.1 M | $ 0.57 | -1.7 % | $ 205 M | ||
|
Celcuity
CELC
|
-449 M | $ 134.95 | 0.17 % | $ 6.31 B | ||
|
Motus GI Holdings
MOTS
|
-154 M | - | -34.28 % | $ 263 K | ||
|
Twist Bioscience Corporation
TWST
|
-1.32 B | $ 48.89 | -7.67 % | $ 2.92 B | ||
|
Neogen Corporation
NEOG
|
-536 M | $ 8.28 | -1.78 % | $ 1.8 B | ||
|
Waters Corporation
WAT
|
10.4 B | $ 332.25 | -0.29 % | $ 19.8 B | ||
|
Quest Diagnostics Incorporated
DGX
|
9.99 B | $ 186.87 | -0.57 % | $ 20.7 B |